Camtek (CAMT) HR VP Orit Geva-Dvash sells 415 shares, holds 5,713

Rhea-AI Filing Summary

CAMTEK LTD vice president of HR, Orit Geva-Dvash, reported a sale of 415 Ordinary Shares of CAMT on 2026-08-12 at $174.0623 per share in an open-market or private transaction. Following this sale, she directly holds 5,713 Ordinary Shares, a balance that includes one additional share previously omitted from her Form 3 due to a rounding error. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 415 shares

Net Sell 1 txn

Insider Geva-Dvash Orit

Role Vice President, HR

Sold 415 shs ($72K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares F1	415	$174.0623	$72K

Holdings After Transaction: Ordinary Shares — 5,713 shares (Direct)

Footnotes (1)

1. F1. The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3 due to a rounding error.

Key Figures

Shares sold: 415 Ordinary Shares Sale price per share: $174.0623 Shares held after transaction: 5,713 Ordinary Shares +2 more

5 metrics

Shares sold 415 Ordinary Shares Non-derivative sale on 2026-08-12

Sale price per share $174.0623 Price per Ordinary Share for the 2026-08-12 sale

Shares held after transaction 5,713 Ordinary Shares Direct ownership following the reported sale

Additional share correction 1 share Previously omitted from Form 3 due to rounding error

Net shares sold 415 shares Net-sell direction per transaction summary

Key Terms

Form 4, Ordinary Shares, rounding error, Rule 10b5-1

4 terms

Form 4 regulatory

"The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Ordinary Shares financial

"The reported transaction involved 415.0000 Ordinary Shares at a price of $174.0623 per share"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

rounding error financial

"One additional share was inadvertently omitted from the reporting person's Form 3 due to a rounding error"

Rule 10b5-1 regulatory

"The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did CAMT executive Orit Geva-Dvash report?

Orit Geva-Dvash reported selling 415 Ordinary Shares of CAMTEK LTD on 2026-08-12 at $174.0623 per share. The transaction was coded as a sale in an open-market or private transaction.

How many CAMTEK LTD (CAMT) shares does Orit Geva-Dvash hold after this Form 4?

After the reported sale, Orit Geva-Dvash directly holds 5,713 Ordinary Shares of CAMTEK LTD. This figure includes one additional share that had been inadvertently omitted from her earlier Form 3 due to a rounding error.

Was the CAMT insider sale by Orit Geva-Dvash under a Rule 10b5-1 plan?

The Form 4 for CAMTEK LTD executive Orit Geva-Dvash does not indicate that the 415-share sale was made under a Rule 10b5-1 trading plan, as the related checkbox was not marked as such.

What was the total value of the 415 CAMT shares sold by Orit Geva-Dvash?

Based on the reported $174.0623 per-share price, the 415 Ordinary Shares sold by Orit Geva-Dvash represent a transaction sized using that price. The Form 4 presents this amount as a per-share figure rather than an aggregate total.

What does the rounding error footnote mean in Orit Geva-Dvash’s CAMT filing?

A footnote explains the post-transaction holding of 5,713 shares includes one additional share that was inadvertently omitted from her original Form 3 due to a rounding error, correcting her previously reported balance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 10:56 AM Accepted by SEC EDGAR 08/13/2026 - 10:56 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geva-Dvash Orit

(Last) (First) (Middle)

EXODUS 6

(Street)

ZICHRON YAAKOV

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President, HR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/12/2026		S		415	D	$174.0623	5,713(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3 due to a rounding error.

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)